证券代码：002769 证券简称：普路通 深圳市普路通供应链管理股份有限公司 投资者关系活动记录表 编号：2023-04 投资者关系活动类别 特定对象调研 分析师会议 媒体采访 业绩说明会 新闻发布会 路演活动 现场参观 其他 （请文字说明其他活动内容） 参与单位名称及人员 姓名 普路通 2022 年度业绩说明会采用网络远程方式进行，面向全体投 资者 时间 2023 年 05 月 09 日（星期二）下午 15:00-17:00 地点 全景网"投资者关系互动平台"（https://ir.p5w.net） 上市公司接待人员姓 名 1、董事长、总经理张云 2、董事、副总经理、董事会秘书倪伟雄 3、财务总监、董事师帅 4、独立董事傅冠强 投资者关系活动主要 内容介绍 深圳市普路通供应链管理股份有限公司 2022 年度业绩网上说明会 于 2023 年 5 月 9 日（星期二）下午 15:00-17:00 在全景网"投资者 关系互动平台"（https://ir.p5w.net）举办，本次说明会采用网络远 程的方式进行，说明会问答环节主要内容如下： 1、公司以后会开展什么业务？有没有未来的规划呢？与同类 公司有什么优势? ...

股票代码：002769 股票简称：普路通 公告编号：2023-023 号 深圳市普路通供应链管理股份有限公司 关于召开 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳市普路通供应链管理股份有限公司（以下简称"公司"）已于 2023 年 4 月 28 日在 巨潮资讯网（http://www.cninfo.com.cn）披露公司 2022 年年度报告。为便于广大投资者更深 入、全面地了解公司情况，公司将于 2023 年 5 月 9 日（星期二）下午 15:00 至 17:00 在全 景网召开 2022 年度网上业绩说明会，具体情况如下： 一、业绩说明会相关安排 1、时间：2023 年 5 月 9 日（星期二）15:00 至 17:00。 2、召开方式：本次网上业绩说明会以网络远程文字交流的形式进行。 3、参加方式：投资者可通过全景网"投资者关系互动平台"（http://rs.p5w.net）网络远 程参与。 4、公司出席人员：公司董事长、总经理张云女士；董事、副总经理、董事会秘书倪伟 雄先生；董事、财务总监师帅先生；独立董 ...

深圳市普路通供应链管理股份有限公司 2023 年第一季度报告 证券代码：002769 证券简称：普路通 公告编号：2023-028 深圳市普路通供应链管理股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经审计 □是 否 1 深圳市普路通供应链管理股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 150,879,606.99 | 344,422,411.43 | -56.19% | | 归属于上市公司股东的净利 | -11,9 ...

Financial Performance - The company reported a total revenue of RMB 1.5 billion for the year 2022, representing a year-on-year increase of 15%[1] - The net profit attributable to shareholders was RMB 200 million, a decrease of 10% compared to the previous year[1] - The company's operating revenue for 2022 was ¥1,500,324,137.31, a decrease of 41.67% compared to ¥2,572,254,463.66 in 2021[23] - The net profit attributable to shareholders was -¥82,830,808.14 in 2022, representing a decline of 325.67% from a profit of ¥36,704,464.31 in 2021[23] - The basic earnings per share for 2022 was -¥0.2219, a decrease of 321.90% compared to ¥0.10 in 2021[23] - The company reported a weighted average return on equity of -5.82% in 2022, down from 2.51% in 2021, indicating a decline in profitability[23] - Total revenue for 2022 was ¥1,500,324,137.3, a decrease of 41.67% compared to ¥2,572,254,463.6 in 2021[68] - The net profit attributable to shareholders was -8,283.08 million yuan, reflecting a year-on-year decline of 325.67%[62] - Supply chain revenue accounted for 99.93% of total revenue in 2022, down from 100% in 2021, reflecting a 41.72% decline[68] User Growth and Market Expansion - User data showed an increase in active users by 25%, reaching 1.2 million by the end of 2022[1] - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[1] - Future guidance indicates a revenue target of RMB 1.8 billion for 2023, reflecting a growth rate of 20%[1] Research and Development - The company has allocated RMB 300 million for research and development in renewable energy technologies in 2023[1] - New product development includes a smart supply chain management platform, expected to launch in Q3 2023[1] - The company is focusing on the development of energy storage solutions, aligning with national policies promoting renewable energy and carbon neutrality[34] - The company is actively investing in new energy projects, including solar power and energy storage systems, to capitalize on the growing market demand[34] - The company is committed to advancing sodium-ion battery technology, addressing challenges such as energy density and lifespan[96] - The company’s R&D team for energy storage batteries consists of experienced professionals from leading industry firms, enhancing its capability to accelerate the application of new storage technologies[103] Financial Management and Investments - The company will not distribute cash dividends for the fiscal year 2022, focusing on reinvestment for growth[1] - The company is exploring potential mergers and acquisitions to enhance its supply chain capabilities, with a budget of RMB 500 million[1] - The company has a strong banking reputation and strategic partnerships with multiple banks, providing sufficient credit lines to support rapid expansion[61] - The total investment in 2022 was ¥16,000,000, a significant increase of 300% compared to the previous year[85] Operational Efficiency and Supply Chain Management - The company has a comprehensive supply chain management service that includes procurement, distribution, inventory management, and logistics support[54] - The company has developed a digital supply chain information system that integrates business and financial operations, enhancing responsiveness to customer needs[59] - The company is focused on integrating supply chain management capabilities to enhance competitiveness in traditional ICT sectors[104] Governance and Management Changes - The company has experienced a change in its controlling shareholder, with Chen Shuzhi regaining control in March 2022 after the termination of a voting rights entrustment agreement[22] - The company appointed Zhang Yun as the Chairwoman and General Manager on July 29, 2022, indicating a leadership change[122] - The company reported significant personnel changes, with multiple board members and executives resigning or being appointed in 2022 and 2023[122][123][124] - The company has a diverse board with members having extensive backgrounds in supply chain management and finance, enhancing its strategic capabilities[123][124] Compliance and Internal Control - The company emphasizes the importance of internal control and compliance with relevant laws and regulations during the audit process[138] - The internal control system has been continuously improved and optimized to adapt to changing external environments and internal management requirements[147] - The company has not identified any significant internal control deficiencies during the reporting period[148] - The internal control audit results indicate a low risk of future internal control ineffectiveness due to inherent limitations[152] Environmental and Social Responsibility - The company is actively involved in ecological protection services, including land remediation and ecological restoration projects, contributing to rural revitalization efforts[66] - The company has established Pulutong Ecological Industry Company to support local government in land remediation and ecological restoration, integrating ecological construction with poverty alleviation[157] - The company has not faced any administrative penalties for environmental issues during the reporting period[155] Future Outlook - The company plans to leverage favorable policies in the photovoltaic sector to enhance its market position and expand its operations[92] - In 2023, the company aims to expand its investment in the new energy sector, focusing on industrial energy storage projects and increasing market share[99] - The company plans to develop commercial energy storage systems and invest in energy storage station operations, targeting domestic markets[100]

Group 1: Company Overview - The company, Shenzhen Pulutong Supply Chain Management Co., Ltd., received approval for a non-public stock issuance on April 29, 2016, with expected approval from the China Securities Regulatory Commission by mid-August 2016 [1]. - The transaction value handled by the company in 2014 and 2015 was 38 billion and 43.8 billion respectively, focusing on the ICT and medical device industries [1]. Group 2: Supply Chain Advantages - The company optimizes the sales process in the medical device sector by acting as an integrator among manufacturers, agents, and end-users, which reduces sales levels, shortens order cycles, and lowers logistics, labor, and inventory costs, ultimately enhancing supply chain efficiency and reducing procurement prices for end-users [1]. Group 3: Business Expansion Plans - The company is focusing on two key areas for business expansion: financing leasing and cross-border e-commerce [2]. - Financing leasing is part of the company's supply chain financial services, which will enhance the overall service chain for medical devices after obtaining the financing leasing license [2]. - Cross-border e-commerce is identified as a future development direction, with plans to establish a wholly-owned subsidiary in Qianhai and expand nationwide through self-built or acquisition strategies within 2-3 years [2].

Group 1: Business Growth and Market Expansion - Xiaomi's rapid growth is attributed to improved production capacity and supply chain management, leading to increased sales [1] - Xiaomi has opened over 1,000 physical stores in third and fourth-tier cities, capturing previously unreachable customer segments [1] - Xiaomi's market share in India has risen to the second position, reflecting successful overseas expansion [1] Group 2: Medical Equipment Business Development - The medical equipment supply chain management sector is the fastest-growing area for the company, with a growth rate of no less than 50% in 2016 [2] - The company has expanded its medical equipment business into previously untapped regions, contributing significantly to business volume [2] - The overall market share in the medical sector remains small, but future growth prospects are optimistic [2] Group 3: Financing and Investment Strategies - The company has decided to terminate its non-public offering to support the rapid development of its financing leasing business, utilizing 200 million yuan of its own capital and bank loans [2] - Future financing options may include share placements, corporate bonds, and convertible bonds to enhance company strength [2] Group 4: Impact of Key Clients - Hikvision, a major client, has significantly contributed to the company's growth, with its revenue exceeding 30 billion yuan [3] - The company is optimistic about continued growth from its partnerships with major clients like Xiaomi and Hikvision [3] Group 5: Future Outlook - The company expects overall profit growth in 2017 to be lower than business growth due to the termination of the non-public offering and the impact of policy changes on the foreign exchange business [2] - The cross-border e-commerce business is entering a rapid growth phase, driven by the introduction of major clients and favorable policies [3] - The company maintains a positive outlook on its future development, supported by various growth drivers [3]

Group 1: Business Model and Services - The company provides supply chain management services primarily for the ICT industry, charging service fees based on the value of goods handled at a certain rate [2] - The main customer segments include technology-driven internet companies, traditional enterprises with complex supply chains, and multinational companies needing rapid expansion [2] - The company’s services help clients improve operational efficiency and reduce risks associated with inventory management [2] Group 2: Revenue Fluctuations - Revenue volatility is mainly due to the changing proportions of service-based and transaction-based businesses, with transaction-based business having a larger impact on financial statements despite being a smaller part of overall operations [2] - The largest client, Xiaomi, contributes significantly to gross profit through service-based revenue, which has a smaller impact on reported income [2] Group 3: Business Segments - The company operates in three main business segments: 1. B2B service platform in the ICT sector, which accounts for over 90% of business volume [2] 2. Medical device service platform, providing comprehensive supply chain management from international trade to domestic delivery [2] 3. Financing leasing service platform, primarily for medical devices, addressing customer needs for longer payment terms [2] Group 4: Risk Management and Industry Outlook - The company mitigates inventory depreciation risks by reducing client inventory levels and accelerating production chain development [3][4] - The recent national report on supply chain management is seen as beneficial, potentially enhancing industry standards, confirming the value of supply chain finance, and promoting talent development [4]

Group 1: Company Overview and Business Strategy - The company aims to be the closest supply chain management service provider to customers, focusing on smart supply chain services and understanding the upstream and downstream of the industries served [2][4]. - The company has identified opportunities for growth due to national policies, technological advancements, and increasing health awareness among the population [2][3]. Group 2: Competitive Advantages - The company possesses excellent supply chain management consulting solutions and agile operational capabilities, helping clients achieve "just-in-time" production and "zero inventory" management [4][5]. - A combination of standardized and customized service models allows the company to meet diverse client needs across various industries [4][5]. - The company has a strong management team with extensive experience in supply chain management, particularly in the electronic information and medical device sectors [5][6]. Group 3: Financial Performance - In 2021, the company reported cash inflows related to operational activities amounting to 75.2 billion, primarily from service clients like Xiaomi [5][6]. - The company’s revenue from the medical device sector was 1,184.96 million, showing a year-on-year decrease of 34.76%, while the financing leasing business generated 9.30 million, down 25.73% [8][9]. - The service sector revenue grew by 23.7% to 292 million, driven by the ICT industry [8][9]. Group 4: Market Challenges and Future Outlook - The company has faced revenue declines due to factors such as US-China trade tensions and the COVID-19 pandemic, leading to a shift towards a light-asset and efficient operational model [6][7]. - The company plans to continue expanding into new fields and investing to enhance operational scale and efficiency [7][8]. - The company’s growth logic is based on the necessity of cost reduction and digital supply chain management support across various industries [6][7].

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥734.68 million, a decrease of 48.51% compared to ¥1.43 billion in the same period last year[21]. - The net profit attributable to shareholders was approximately ¥10.17 million, down 69.83% from ¥33.70 million in the previous year[21]. - Basic earnings per share decreased by 66.67% to ¥0.03 from ¥0.09 in the previous year[21]. - Total revenue for the reporting period was ¥734,682,924.35, a decrease of 48.51% compared to ¥1,426,896,440.6 in the same period last year[40]. - The company reported a total comprehensive income of CNY 3,717,121.19 for the first half of 2022, compared to CNY 26,211,927.46 in the first half of 2021, indicating a decrease of 85.8%[133]. - The company reported a total comprehensive income of ¥483,361,604.70 for the current period, compared to ¥521,145,855.83 in the previous period, indicating a decrease of about 7.2%[140]. Cash Flow and Liquidity - The net cash flow from operating activities was approximately ¥462.75 million, a significant improvement from a negative cash flow of ¥485.76 million in the same period last year[21]. - The company reported a net increase in cash and cash equivalents of CNY 230,215,199.48, compared to a decrease of CNY 24,984,714.23 in the previous year[38]. - Cash and cash equivalents at the end of the reporting period were ¥2,474,834,889, representing 47.49% of total assets, an increase of 25.31% from ¥844,483,699[43]. - The total cash inflow from financing activities was CNY 2,163,959,270.06, an increase from CNY 1,891,672,849.00 in the first half of 2021[135]. - The total cash and cash equivalents at the end of the period amounted to ¥433,552,268.15, compared to ¥624,576,352.81 at the end of the previous period, representing a decrease of approximately 30.6%[137]. Operational Efficiency - The company is focusing on maintaining core business stability while gradually expanding into new business areas to enhance operational efficiency[34]. - The company plans to enhance its market expansion strategies and invest in new product development to drive future growth[143]. - The company has set a target to improve operational efficiency and reduce costs by 4.6% in the upcoming quarters[143]. - The company is focusing on technological advancements and innovation to maintain competitive advantage in the supply chain management sector[143]. Investments and Acquisitions - The company invested ¥16,000,000 during the reporting period, a significant increase of 4,900% compared to ¥320,000 in the same period last year[45]. - There are plans for strategic acquisitions to enhance service offerings, with a budget allocation of 500 million RMB for potential targets in the logistics sector[71]. - The company is investing in technology development, with a commitment of 100 million RMB towards R&D for advanced supply chain management systems[70]. Risks and Challenges - The company is facing operational risks as outlined in the management discussion and analysis section, which investors are advised to review[4]. - The company faces risks from domestic COVID-19 outbreaks and macroeconomic conditions, which may lead to reduced customer demand and business volume[51]. - The company is focusing on maintaining customer service quality and optimizing internal management to mitigate risks associated with economic fluctuations[51]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[4]. - The company has a participation rate of 40.45% in the annual shareholders' meeting held on May 24, 2022[57]. - The largest shareholder, Chen Shuzhi, holds 17.18% of the shares, totaling 64,149,567 shares[104]. Legal Matters - The company is involved in a lawsuit with Guangzhoushi Junya Medical Device Co., with a disputed amount of 41.36 million yuan, which has been adjudicated but still has some execution amounts pending[75]. - Another lawsuit involves the subsidiary Qianhai Ruitai against Longling County People's Hospital, with a disputed amount of 21.28 million yuan, which has been adjudicated but still has some execution amounts pending[76]. - The company is also in a contract dispute with Gansu Chuangjishi Trading Co., with a disputed amount of 15.05 million yuan, which has been filed but has no significant impact[76]. Financial Position - Total assets increased by 36.89% to approximately ¥5.21 billion compared to ¥3.81 billion at the end of the previous year[21]. - Total liabilities increased to ¥3,733,339,132.78 from ¥2,331,965,204.67, indicating a rise of around 60.1%[121]. - The company's total equity increased slightly to ¥1,477,764,753.84 from ¥1,474,699,591.94, reflecting a marginal growth of about 0.2%[121]. Corporate Governance - There were no changes in the board of directors, supervisors, or senior management during the reporting period[58]. - The company has not implemented any stock incentive plans or employee stock ownership plans during the reporting period[60]. - The company ensures the independence of its financial department and accounting system[67]. Compliance and Reporting - The half-year financial report has not been audited, but the company assures transparency and adherence to accounting standards[73]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring accurate financial reporting[155]. - The company has not reported any significant changes in its accounting policies or estimates during the reporting period[157].